Humana Cash Flow Statement
NYSE: HUMHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Humana free cash flow
In fiscal 2025, Humana generated $921.0 million of operating cash flow and spent $546.0 million on capital expenditures. That left free cash flow of $375.0 million, a free-cash-flow margin of 0.3% of revenue. Free cash flow was down 84.3% from the prior year's $2.39 billion.
Humana returned $581.0 million to shareholders: $430.0 million in dividends and $151.0 million in share repurchases, equal to 155% of free cash flow. Free cash flow covered dividend payments 0.9 times.
Summary generated from market data by MetaCap's automated system. Methodology
Humana cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.20B | 1.21B | 2.48B | 2.80B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M |
| Net Income growth (YoY) | -0.91% | -51.13% | -11.35% | -4.50% | -12.86% | +24.38% | +60.84% | -31.25% | +298.70% | -51.88% |
| Depreciation & Amortization | 698.00M | 839.00M | 779.00M | 709.00M | 596.00M | 528.00M | 505.00M | 444.00M | 410.00M | 388.00M |
| Stock-Based Compensation | 241.00M | 207.00M | 175.00M | 216.00M | 180.00M | 181.00M | 163.00M | 137.00M | 157.00M | 115.00M |
| Change in Working Capital | -1.32B | -45.00M | -834.00M | -441.00M | -660.00M | 4.00M | 521.00M | -1.42B | 583.00M | 1.12B |
| Operating Cash Flow | 921.00M | 2.97B | 3.98B | 4.59B | 2.26B | 5.64B | 5.28B | 2.17B | 4.05B | 1.94B |
| Capital Expenditures | -546.00M | -575.00M | -1.00B | -1.14B | -1.34B | -964.00M | -736.00M | -612.00M | -524.00M | -527.00M |
| Investing Cash Flow | 2.27B | -2.95B | -3.49B | -1.01B | -6.56B | -3.06B | -1.28B | -3.09B | -2.94B | -1.36B |
| Dividends Paid | -430.00M | -431.00M | -431.00M | -392.00M | -354.00M | -323.00M | -291.00M | -265.00M | -220.00M | -177.00M |
| Share Repurchases | -151.00M | -817.00M | -1.57B | -2.10B | -79.00M | -1.82B | -1.07B | -1.09B | -3.37B | -104.00M |
| Debt Issued | 1.48B | 2.23B | 2.54B | 1.98B | 2.98B | 1.09B | 987.00M | 0 | 1.78B | 0 |
| Debt Repaid | -948.00M | -1.11B | -1.83B | -1.00B | 0 | -400.00M | -400.00M | 0 | -800.00M | 0 |
| Financing Cash Flow | -1.22B | -2.49B | -856.00M | -1.91B | 3.02B | -1.96B | -2.29B | -785.00M | -945.00M | 732.00M |
| Net Change in Cash | 1.98B | -2.47B | -367.00M | 1.67B | -1.28B | 619.00M | 1.71B | -1.70B | 165.00M | 1.31B |
| Free Cash Flow | 375.00M | 2.39B | 2.98B | 3.45B | 920.00M | 4.67B | 4.55B | 1.56B | 3.53B | 1.41B |
This table shows 10 annual periods of Humana's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HUM's reporting calendar. What is a cash flow statement?